West Pharmaceutical Services, Inc. (WST)

WST Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	467.2	492.7	593.4	585.9	661.8	346.2
Depreciation & Amortization	159.8	155.4	137.3	120.6	122.3	109.1
Loss (Gain) From Sale of Assets	-	-	11.6	-	-	-
Asset Writedown & Restructuring Costs	7.8	7.3	9.6	21.5	5.6	7.7
Loss (Gain) on Equity Investments	-13.4	-13.4	-14.3	-18.1	-17.4	-15.8
Stock-Based Compensation	15	18.7	23.3	23.7	37.5	34
Other Operating Activities	-9.4	-10.2	36	5.4	-27.7	1.6
Change in Accounts Receivable	-58.8	-58.8	4	-35.6	-123.5	-46.6
Change in Inventory	42	42	-13.5	-49.8	-86.5	-73.7
Change in Accounts Payable	2.9	2.9	4.4	-2.8	16.8	36.6
Change in Other Net Operating Assets	51.5	16.8	-15.3	73.2	-4.9	73.4
Operating Cash Flow	664.6	653.4	776.5	724	584	472.5
Operating Cash Flow Growth	-12.16%	-15.85%	7.25%	23.97%	23.60%	28.68%
Capital Expenditures	-357.7	-377	-362	-284.6	-253.4	-174.4
Cash Acquisitions	-	-	-	-	-2.2	-
Other Investing Activities	-1.7	-1.7	-6.7	-3.6	2.5	-5.1
Investing Cash Flow	-359.4	-378.7	-368.7	-288.2	-253.1	-179.5
Long-Term Debt Issued	-	164.7	-	-	-	-
Total Debt Issued	164.7	164.7	-	-	-	-
Long-Term Debt Repaid	-	-192.3	-2.4	-44.3	-2.2	-2.3
Total Debt Repaid	-191.8	-192.3	-2.4	-44.3	-2.2	-2.3
Net Debt Issued (Repaid)	-27.1	-27.6	-2.4	-44.3	-2.2	-2.3
Issuance of Common Stock	20.3	32.7	51	28.2	37.1	34.7
Repurchase of Common Stock	-430.2	-566.6	-451.2	-222.2	-151.9	-121.4
Common Dividends Paid	-59.6	-59.1	-57	-54.1	-51.1	-48.1
Other Financing Activities	-2	-2	-	-1.2	-	-
Financing Cash Flow	-498.6	-622.6	-459.6	-293.6	-168.1	-137.1
Foreign Exchange Rate Adjustments	-4.2	-21.4	11.4	-10.5	-15.7	20.5
Net Cash Flow	-197.6	-369.3	-40.4	131.7	147.1	176.4
Free Cash Flow	306.9	276.4	414.5	439.4	330.6	298.1
Free Cash Flow Growth	-20.51%	-33.32%	-5.67%	32.91%	10.90%	23.80%
Free Cash Flow Margin	10.60%	9.55%	14.05%	15.22%	11.68%	13.88%
Free Cash Flow Per Share	4.18	3.75	5.50	5.80	4.33	3.93
Cash Interest Paid	0.5	0.5	6	6.6	8	8.1
Cash Income Tax Paid	71.4	71.4	90.8	109.7	171.8	48.4
Levered Free Cash Flow	233.51	206.73	196.35	246.54	210.05	250.4
Unlevered Free Cash Flow	234.64	208.6	201.98	251.48	215.18	255.53
Change in Net Working Capital	-44.6	-40.5	38	85.6	171.6	-22.7

Updated Apr 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q